Researcher.Life Logo

International Journal of Neuropsychopharmacology : Impact Factor & More

eISSN: 1469-5111pISSN: 1461-1457
JournalOpen Access

Aims and Scope of International Journal of Neuropsychopharmacology

The International Journal of Neuropsychopharmacology is a peer-reviewed scientific journal published by Oxford University Press. It is an official journal of the Collegium Internationale Neuro-Psychopharmacologicum (CINP) (International College of Neuro-Psychopharmacology) and covers basic and clinical topics in neuropharmacology and psychopharmacology. It was established in 1998 by Bernard Lerer, who served as editor-in-chief until 2008. Less

Key Metrics

CiteScore
9.1
H-Index
119
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
1.45
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on International Journal of Neuropsychopharmacology

International Journal of Neuropsychopharmacology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher OXFORD UNIV PRESS
Language English
Frequency Monthly
Article Processing ChargesGBP 1945
Publication Time12
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorCollegium Internationale Neuro-Psychopharmacologicum (CINP)
FrequencyMonthly
Publication Start Year1998
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 12
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in International Journal of Neuropsychopharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in International Journal of Neuropsychopharmacology

Negative allosteric modulator of the metabotropic glutamate receptor 7 (mGlu7) ADX71743 increases wakefulness, reduces sleep and alters stress-induced changes in the brain neurotransmitter levels.
  • 11 May 2026
  • The international journal of neuropsychopharmacology
Trials, Trips, and Tribulations: Pathways for Implementing Psychedelic therapy in Ireland.
  • 11 May 2026
  • The international journal of neuropsychopharmacology
Life Engagement Improvements with Cariprazine in Schizophrenia: A Post-Hoc Analysis of PANSS Data from Short-Term Studies.
  • 8 May 2026
  • The international journal of neuropsychopharmacology
Late-onset major depression and subthreshold depressive symptoms as early clinical correlates of brain small vessel disease.
  • 8 May 2026
  • The international journal of neuropsychopharmacology
The introduction of measurement-based care for patients with schizophrenia may improve psychiatric symptoms and guideline adherence rate.
  • 8 May 2026
  • The international journal of neuropsychopharmacology
Heterogeneity in adverse events associated with lumateperone: a study on potential subgroup-specific differences.
  • 8 May 2026
  • The international journal of neuropsychopharmacology
Negative allosteric modulator of the metabotropic glutamate receptor 7 (mGlu7) ADX71743 increases wakefulness, reduces sleep and alters stress-induced changes in the brain neurotransmitter levels.
  • 11 May 2026
  • The international journal of neuropsychopharmacology
Trials, Trips, and Tribulations: Pathways for Implementing Psychedelic therapy in Ireland.
  • 11 May 2026
  • The international journal of neuropsychopharmacology
Life Engagement Improvements with Cariprazine in Schizophrenia: A Post-Hoc Analysis of PANSS Data from Short-Term Studies.
  • 8 May 2026
  • The international journal of neuropsychopharmacology
Late-onset major depression and subthreshold depressive symptoms as early clinical correlates of brain small vessel disease.
  • 8 May 2026
  • The international journal of neuropsychopharmacology
The introduction of measurement-based care for patients with schizophrenia may improve psychiatric symptoms and guideline adherence rate.
  • 8 May 2026
  • The international journal of neuropsychopharmacology
Heterogeneity in adverse events associated with lumateperone: a study on potential subgroup-specific differences.
  • 8 May 2026
  • The international journal of neuropsychopharmacology

FAQs on International Journal of Neuropsychopharmacology